Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with Ritali
Not Applicable
- Conditions
- attention deficiency hyperactivity disorder.Disturbance of activity and attention
- Registration Number
- IRCT201110127462N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
diagnostic criteria based on DSM IV for children with ADHD, age range 11-18, no consumption of any effective psychological drugs in past two week
Exclusion criteria: mental retardation, any other psychological disorders except for ODD, history of allergy to Duloxetine, serious medical conditions such as heart disease, uncontrolled convulsive disorder, systolic pressure upper than 125 mmhg or resting pulse less than 60 or more than 115 bit/m
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attention deficiency hyperactivity disorder. Timepoint: Baseline, 2, 4, 6, 8 weeks after treatment. Method of measurement: CANERS test for parents (summerized and edited format) and ADHD rating scale for parents and teacher.
- Secondary Outcome Measures
Name Time Method Drugs side effects. Timepoint: Baseline, 2,4,6,8 weeks after treatment. Method of measurement: side effect questionnaire.